Centessa Pharmaceuticals plc
CNTA
$39.59
-$0.02-0.05%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -197.53M | -242.70M | -230.37M | -223.85M | -235.76M |
| Total Depreciation and Amortization | 321.00K | 310.00K | 309.00K | 319.00K | 342.00K |
| Total Amortization of Deferred Charges | 1.76M | 1.48M | 1.21M | 912.00K | 600.00K |
| Total Other Non-Cash Items | 31.67M | 66.18M | 67.75M | 67.70M | 70.60M |
| Change in Net Operating Assets | -30.03M | -6.07M | 17.22M | -7.10M | 22.16M |
| Cash from Operations | -193.82M | -180.81M | -143.89M | -162.02M | -142.06M |
| Capital Expenditure | -371.00K | -360.00K | -160.00K | -34.00K | -34.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -418.16M | -175.04M | -192.22M | -207.85M | 31.30M |
| Cash from Investing | -418.53M | -175.40M | -192.38M | -207.88M | 31.27M |
| Total Debt Issued | -- | 109.34M | 109.34M | 109.34M | 109.34M |
| Total Debt Repaid | -- | -110.10M | -110.10M | -110.10M | -110.10M |
| Issuance of Common Stock | 296.72M | 18.45M | 261.84M | 368.21M | 370.83M |
| Repurchase of Common Stock | -4.79M | -6.20M | -7.05M | -5.32M | -5.32M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -401.00K | -396.00K | -396.00K | -4.79M | -- |
| Cash from Financing | 291.53M | 11.09M | 253.64M | 357.35M | 364.75M |
| Foreign Exchange rate Adjustments | -448.00K | 901.00K | -502.00K | -509.00K | 1.23M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -321.27M | -344.22M | -83.13M | -13.06M | 255.19M |